Alkyl Amines Chemicals Limited AI Stock Analysis
Want to see IN:ALKYLAMINE full AI Analyst Report?
Alkyl Amines Chemicals Limited (ALKYLAMINE) AI Stock Analysis
Alkyl Amines Chemicals Limited
(NSE:ALKYLAMINE)
The overall score is driven mainly by the company’s strong financial resilience, with a robust, low-debt balance sheet and solid cash generation, balanced against recent margin compression and softer growth. The technical picture is constructive, with the price in an uptrend but momentum only moderately positive. A relatively demanding valuation, with a high P/E and modest dividend yield, tempers the attractiveness of the stock at current levels.
Alkyl Amines Chemicals Limited (ALKYLAMINE) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 79.60B
- Dividend Yield
- 0.64%
- Average Volume (3M)
- 6,405
- Price to Earnings (P/E)
- 32.5
- Beta (1Y)
- 0.88
- Revenue Growth
- 13.38%
- EPS Growth
- 35.82%
- Country
- India
- Employees
- 692
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
Alkyl Amines Chemicals Limited Business Overview & Revenue Model
Company Description
Alkyl Amines Chemicals Limited functions as a global producer and purveyor of a diverse portfolio of chemical substances, encompassing various amines, their derivatives, and a selection of specialized chemicals. The company's offerings include alipha...
Alkyl Amines Chemicals Limited Financial Statement Overview
Summary
Score reflects a very conservative, low-debt balance sheet and consistently positive operating cash flows, offset by compressed profit margins, softer revenue growth, and volatile free cash flow compared with prior years.
Income Statement
68PositiveBalance Sheet
83Very PositiveCash Flow
72Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.06B | 15.36B | 15.72B | 14.41B | 16.83B | 15.42B |
| Gross Profit | 5.53B | 5.35B | 7.14B | 6.54B | 8.04B | 6.92B |
| EBITDA | 3.20B | 3.16B | 2.98B | 2.55B | 3.49B | 3.27B |
| Net Income | 2.05B | 1.80B | 1.86B | 1.49B | 2.29B | 2.25B |
Balance Sheet | ||||||
| Total Assets | 20.34B | 18.95B | 17.89B | 15.84B | 15.90B | 13.71B |
| Cash, Cash Equivalents and Short-Term Investments | 2.57B | 2.51B | 2.03B | 303.92M | 171.95M | 615.33M |
| Total Debt | 198.00M | 11.90M | 55.20M | 31.68M | 877.50M | 232.89M |
| Total Liabilities | 3.93B | 3.62B | 3.86B | 3.16B | 4.21B | 3.82B |
| Stockholders Equity | 16.42B | 15.33B | 14.02B | 12.67B | 11.69B | 9.90B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 1.10B | 2.15B | 1.53B | -550.40M | -422.81M |
| Operating Cash Flow | 0 | 2.39B | 2.63B | 2.75B | 2.48B | 2.05B |
| Investing Cash Flow | 0 | -1.37B | -1.96B | -1.21B | -2.77B | -2.06B |
| Financing Cash Flow | 0 | -560.90M | -491.50M | -1.40B | 80.00M | -572.89M |
Alkyl Amines Chemicals Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ALKYLAMINE, the sentiment is Negative. The current price of 1574.65 is below the 20-day moving average (MA) of 1619.44, below the 50-day MA of 1755.42, and below the 200-day MA of 1686.49, indicating a bearish trend. The MACD of -49.87 indicates Negative momentum. The RSI at 37.25 is Neutral, neither overbought nor oversold. The STOCH value of 40.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ALKYLAMINE.
Alkyl Amines Chemicals Limited Peers Comparison
Overall Rating
IN:ALKYLAMINE70.6Outperform
IN:VINATIORGA68Neutral
IN:JUBLINGREA61Neutral
IN:BALAMINES57.5Neutral
IN:AARTIIND47Neutral
IN:LXCHEM47Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 71Outperform | INR 80.54B | 32.52 | ― | 0.64% | 13.38% | 35.82% | |
| 68Neutral | INR 121.70B | 29.52 | ― | 0.72% | 10.98% | -5.48% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 61Neutral | INR 91.41B | 25.83 | ― | 0.87% | 15.41% | 21.76% | |
| 58Neutral | INR 60.83B | 25.60 | ― | 0.59% | 20.91% | 62.44% | |
| 47Neutral | INR 165.88B | 28.02 | ― | 0.22% | 39.85% | 103.71% | |
| 47Neutral | INR 42.80B | 24.88 | ― | 0.19% | 21.34% | 105.39% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:ALKYLAMINE | Alkyl Amines Chemicals Limited | 1574.65 | -132.77 | -7.78% | |
| IN:AARTIIND | AARTI Industries Ltd | 457.30 | 77.66 | 20.45% | |
| IN:BALAMINES | Balaji Amines Limited | 1877.45 | 761.38 | 68.22% | |
| IN:JUBLINGREA | Jubilant Ingrevia Ltd. | 573.90 | -129.61 | -18.42% | |
| IN:LXCHEM | Laxmi Organic Industries Ltd. | 154.00 | -29.99 | -16.30% | |
| IN:VINATIORGA | Vinati Organics Limited | 1173.95 | -427.59 | -26.70% |
Alkyl Amines Chemicals Limited Corporate Events
Alkyl Amines shareholders clear board restructuring and leadership extensions
Alkyl Amines Chemicals Limited has secured shareholder approval via postal ballot and remote e-voting for a suite of special resolutions that reshape its senior leadership structure. Key changes include the re-designation of Yogesh M. Kothari as Exec...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 07, 2026
